Poxel (XPAR:POXEL) Net Change in Cash : €-8.55 Mil (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Poxel Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Poxel's Net Change in Cash for the six months ended in Jun. 2023 was €-5.46 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 was €-8.55 Mil.

Poxel Net Change in Cash Historical Data

The historical data trend for Poxel's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Net Change in Cash Chart

Poxel Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Change in Cash

Get a 7-Day Free Trial

13.32

-29.55

3.02

-7.91

-19.23

Poxel Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Net Change in Cash	Get a 7-Day Free Trial															-3.28	-4.63	-16.15	-3.08	-5.46

Poxel Net Change in Cash Calculation

Poxel's Net Change in Cash for the fiscal year that ended in Dec. 2022 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-21.813	+	0	+	2.585	+	-0.001
	=	-19.23

Poxel's Net Change in Cash for the quarter that ended in Jun. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -7.841 + 0.007 + 2.381 + -0.008

= -5.46

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-8.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poxel Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Poxel's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Poxel Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Net Change in Cash

Comparable Companies

XPAR:FALG XPAR:ALHYG XPAR:ALCOX XPAR:ALTHX XPAR:ALNFL XPAR:ALPAT XPAR:ALINT XPAR:ALVET XPAR:SIGHT XPAR:ALBPS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

0RA2:UK 7PO:Germany

Address

259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007

Website

https://www.poxel.com

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel Headlines

No Headlines